• Explore /
  • Poster
  • / Study RC48-C014: Preliminary results of RC48-ADC combined with toripalimab in patients with locally advanced or metastatic urothelial carcinoma.

Study RC48-C014: Preliminary results of RC48-ADC combined with toripalimab in patients with locally advanced or metastatic urothelial carcinoma.

Abstract Poster

Authors

null

Li Zhou

Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Genitourinary Oncology, Peking University Cancer Hospital & Institute, Beijing, China

Li Zhou , Huayan Xu , Siming Li , Xieqiao Yan , Juan Li , Xiaowen Wu , Zhihong Chi , Lu Si , Chuanliang Cui , Yan Kong , Bixia Tang , Lili Mao , Bin Lian , Xue Bai , Xuan Wang , Hongqian Guo , Zhisong He , Jun Guo , Xinan Sheng

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Urothelial Carcinoma

Track

Urothelial Carcinoma

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT04264936

Citation

J Clin Oncol 40, 2022 (suppl 6; abstr 515)

DOI

10.1200/JCO.2022.40.6_suppl.515

Abstract #

515

Poster Bd #

G4

Abstract Disclosures

Similar Posters

First Author: Xinan Sheng

First Author: Li Zhou

First Author: Xinan Sheng

First Author: Jonathan E. Rosenberg